---
$id: https://graph.org.ai/products/commodity/51171855
$type: Product
source: UNSPSC
code: "51171855"
title: "Clebopride"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clebopride

**UNSPSC Code**: 51171855
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine antagonist with the molecular formula C20H24ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0A84520Y9, chemically known as benzamide, 4-amino-5-chloro-2-methoxy-n-(1-(phenylmethyl)-4-piperidinyl)- but generally known as clebopride, which bears US NIH Compound Identifier 2780. European Medicines Agency schedules Clebopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06646MIG. The term CLEBOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules clebopride in its Anatomical Therapeutic Chemical (ATC) Classification. CLEBOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clebopride under HS 29333999 and SITC 51574. As of Q4 2014, CLEBOPRIDE remains the US FDA Preferred Term for this commodity. Clebopride bears US NLM identifiers UMLS ID C0055869 and NCI Concept Code C83627. SMILES: CLC1CC(C(=O)NC2CCN(CC2)CC2CCCCC2)C(OC)CC1N.

